CellFE Inc, a developer of a microfluidics-based device to deliver gene-editing molecules, has raised $4.8 million in financing. Dynamk Capital and Cota Capital led the round with participation from Embark Ventures, Elm Ventures and McEwan Lane Family Trust.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: